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Lens epithelium–derived growth factor (LEDGF)/dense fine speckles 70 kDa protein (DFS70) is a transcription
cofactor that enhances growth and is overexpressed in various cancers. In the epidermis, LEDGF/DFS70 localizes
to the nucleus of keratinocytes (KCs) in the basal layers and to the cytoplasm of cells in the upper layers.
However, the biological and pathological relevance of LEDGF/DFS70 in the epidermis is virtually unknown.
Compared with normal epidermis, we detected strong nuclear staining of LEDGF/DFS70 in both the spinous and
basal layers of the epidermis of psoriatic skin. To investigate the roles of LEDGF/DFS70 in the epidermis of
psoriatic skin, we generated HaCaT cells that constitutively express enhanced green fluorescence protein
(EGFP)-LEDGF (EGFP-LEDGF-HaCaT) or EGFP alone (EGFP-HaCaT) as a control. EGFP-LEDGF-HaCaT cells had
increased expression of IL-6, which was attenuated by LEDGF-specific RNA interference and the p38-specific
inhibitors SB-239063 and SB-203580. Furthermore, EGFP-LEDGF-HaCaT cells had increased expression of S100A7
and S100A9 and decreased expression of filaggrin. These findings are compatible with the expression pattern in
psoriatic tissues. Taken together, these results strongly suggest that ectopic expression of LEDGF/DFS70 in KCs
could be involved in the pathology of psoriasis vulgaris.
Journal of Investigative Dermatology (2010) 130, 2760–2767; doi:10.1038/jid.2010.203; published online 15 July 2010
INTRODUCTION
Lens epithelium–derived growth factor (LEDGF)/dense fine
speckles 70 kDa protein (DFS70) was isolated as a transcrip-
tion cofactor (Ge et al., 1998), a survival factor (Singh et al.,
1999), and a target of autoantibodies in atopic dermatitis
(Ochs et al., 2000). LEDGF/DFS70 is induced by tumor
necrosis factor-a, oxidative stress, and hyperthermia
(Shinohara et al., 2002; Nguyen et al., 2003). In addition, it
has been linked to various diseases; anti-LEDGF/DFS70
autoantibodies have been detected in autoimmunity (Muro,
2001), and LEDGF/DFS70 has been shown to bind to HIV-1
integrase (Ciuffi and Bushman, 2006). Furthermore, LEDGF/
DFS70 has been implicated as having a key role in cancer
and other multiplication diseases (Ahuja et al., 2000;
Daugaard et al., 2007; Huang et al., 2007). For example,
there is an association between LEDGF/p75 overexpression
and chemoresistance in acute myelogenous leukemia (Huang
et al., 2007), and LEDGF/DFS70 expression is increased
in human prostate, breast, and bladder carcinomas and
correlates with Hsp70-2 expression in invasive bladder
cancer (Daugaard et al., 2007; Mediavilla-Varela et al.,
2009). Moreover, LEDGF was recently shown to interact with
Cdc7–ASK (activator of S-phase kinase), which is essential
for initiating DNA replication throughout S phase, and
LEDGF/DFS70 was shown to stimulate its enzymatic activity
(Hughes et al., 2010).
Through studies on LEDGF/DFS70 and autoantibodies to
this molecule (Ogawa et al., 2004; Okamoto et al., 2004;
Watanabe et al., 2004), we recently found that LEDGF/DFS70
is located predominantly in the nucleus of basal epidermal cells
and translocate to the cytoplasm during their differentiation
(Sugiura et al., 2007). We further conducted immunohisto-
chemical analyses of LEDGF/DFS70 in various skin diseases
and determined that LEDGF/DFS70 expression is deregulated
in the nucleus of keratinocytes (KCs) in the spinous layers of
psoriatic lesions. Therefore, we speculate that LEDGF/DFS70
may have pivotal roles in the nuclei of KCs in this disease.
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Psoriasis is a common skin disorder that is characterized
by epidermal hyperplasia, T-cell recruitment, and changes in
the endothelial vascular system (Bos et al., 2005; Bowcock
and Krueger, 2005; Krueger and Ellis, 2005). It has been
suggested that psoriatic KCs have abnormal expression and/or
activation of various transcription factors and deregulation
of several signaling pathways (McKenzie and Sabin, 2003;
Johansen et al., 2004). For example, IL-6 levels are
significantly increased in psoriatic lesion samples (Ameglio
et al., 1997). In addition, psoriatic KCs are characterized
by activation of signal transducer and activator of transcrip-
tion 3 (STAT3) (Sano et al., 2005). Moreover, the activity of
mitogen-activated protein kinase (MAPK) p38 is increased in
lesional psoriatic skin (Johansen et al., 2005; Yu et al., 2007).
IL-6 is a multifunctional cytokine, and one of its functions
is to activate target genes involved in cell proliferation.
It signals through a heterodimeric IL-6R/gp130 complex
that triggers the activation of the Janus (JAK) kinases and
downstream effectors, including STAT3. STAT3 participates
in cellular transformation and oncogenesis (Bromberg et al.,
1999; Hodge et al., 2005). Activated STAT3, in turn, is
transported into the nucleus, where it functions as a trans-
cription factor that regulates genes involved in cell survival
(Battle and Frank, 2002).
Although LEDGF/DFS70 is a well-characterized survival
factor in KCs (Shinohara et al., 2002), the relationship
between LEDGF/DFS70 and growth factors such as IL-6 has
not been well characterized. Therefore, the aim of this study
was to determine the mechanism by which this protein
functions as a survival factor in psoriasis vulgaris. To facilitate
these studies and investigate the relationship between
LEDGF overexpression and IL-6 production and STAT3
activation, we generated HaCaT cells that constitutively
express enhanced green fluorescence protein (EGFP)-LEDGF
(EGFP-LEDGF-HaCaT) or EGFP alone (EGFP-HaCaT) as a
control. We further examined whether IL-6 production in
EGFP-LEDGF-HaCaT cells is inhibited by the p38-specific
inhibitors SB-239063 and SB-203580 because p38 MAPKs
were previously reported to regulate IL-6 expression (Zarubin
and Han, 2005; Cuenda and Rousseau, 2007). Finally, we
used western blotting to examine the expression of S100A7,
S100A9, and filaggrin, which are known to be altered in
psoriatic tissues, in EGFP-LEDGF-HaCaT cells compared with
EGFP-HaCaT cells.
RESULTS
Strong nuclear staining of LEDGF/DFS70, pY-STAT3, and
p-p38 in the epidermis of psoriatic lesions
First, we conducted immunohistochemical analyses of
LEDGF/DFS70, pY-STAT3, and phosphorylated p38 (p-p38)
in psoriasis vulgaris skin lesions. Figure 1 shows that LEDGF/
DFS70 and p-p38 are strongly expressed in the nuclei in
both the spinous and basal layers of psoriatic skin (Figure 1a
and e) compared with cytoplasmic staining in normal
skin (Figure 1b and f), and this staining pattern was found
in 90% of psoriatic skin (n¼9 of 10). STAT3 activation was
significantly greater in the nucleus of psoriatic KCs (Figure 1c)
than in normal skin (Figure 1d).
We next conducted immunocytochemical analyses of
HaCaT cells under serum-free conditions. Serum starvation
for 72 hours increased the proportion of cells in the G0/G1
phase (Qi et al., 2006). As shown in Supplementary Figure S1
online, LEDGF was located in the cytoplasm of HaCaT cells
under serum-free conditions. Ki-67 is a cell cycle marker that
is not expressed in the G0 phase (Verheijen et al., 1989).
However, LEDGF localized to the nucleus when cells were
incubated in DMEM containing 10% fetal bovine serum.
Our findings suggest that LEDGF localizes to the cytoplasm
when cells are in the G0/G1 phase and localizes to the
nucleus in proliferating cells in vitro. These findings are
compatible with immunohistochemical analyses of LEDGF/
DFS70 in psoriasis vulgaris skin lesions and normal epidermis
specimens (Figure 1a and b).
LEDGF production in transgenic EGFP-LEDGF-HaCaT cells
To investigate the function of LEDGF/DFS70 in KCs, we
generated HaCaT cells constitutively expressing EGFP-
LEDGF (EGFP-LEDGF-HaCaT) or EGFP alone (EGFP-HaCaT).
Figure 1. Immunohistochemistry of psoriatic and normal epidermis.
The epidermis from psoriatic lesions from psoriasis patients (a, c, e) and
normal skin from healthy donors (b, d, f) were stained with anti-LEDGF (a, b),
anti-pY-STAT3 (c, d), and anti-p-p38 (e, f) antibodies. Scale bars¼ 50mm.
LEDGF, lens epithelium–derived growth factor; p-p38, phosphorylated p38;
STAT3, signal transducer and activator of transcription 3.
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As shown in Figure 2c, microscopic analyses of EGFP-
LEDGF-HaCaT cells that were incubated for 24 hours showed
that the signals for EGFP fluorescence (Figure 2a) colocalized
with the blue fluorescence representing nuclear staining
by 4,6-diamidino-2-phenylindole (Figure 2b). These data
indicated that EGFP-LEDGF localized to both nuclei and
cytoplasm in EGFP-LEDGF-HaCaT cells compared with
EGFP-HaCaT cells (Figure 2d–f). After incubating for 72 hours,
the EGFP-LEDGF-HaCaT cells had reached 70% confluency
and the expression of LEDGF mRNA and EGFP-LEDGF
protein had increased, as determined by quantitative PCR
and western blot analyses, respectively (Figure 2g and h).
LEDGF/DFS70 induced IL-6 mRNA and protein expression and
phosphorylated STAT3
Next, we investigated whether IL-6 was upregulated in EGFP-
LEDGF-HaCaT cells when compared with EGFP-HaCaT cells
using quantitative PCR and ELISAs. These analyses showed
that EGFP-LEDGF-HaCaT cells had higher IL-6 expression
at both the mRNA and protein levels (Figure 3a and b).
We also performed western blot analyses to determine
whether STAT3 phosphorylation increased. As shown
in Figure 3c, STAT3 was more highly phosphorylated
in EGFP-LEDGF-HaCaT cells than in EGFP-HaCaT cells. To
ascertain whether LEDGF/DFS70 regulates IL-6 expression,
we used small interference RNA (siRNA) to knock down
LEDGF (siLED) or a control (siCD4) in EGFP-LEDGF-HaCaT
cells and then examined the IL-6 mRNA and protein levels
(Supplementary Figure S2 online). We validated the effect of
LEDGF siRNA and determined that reduced LEDGF/DFS70
expression was associated with reduced IL-6 expression.
Effects of MAPK inhibitors on increased IL-6 expression in
EGFP-LEDGF-HaCaT cells
As shown in Figure 3, LEDGF overexpression resulted in
increased IL-6 expression at both the mRNA and protein
levels, and IL-6 expression was regulated by p38 MAPKs
(Zarubin and Han, 2005; Cuenda and Rousseau, 2007).
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Figure 2. Increased expression of LEDGF in EGFP-LEDGF-HaCaT cells. After incubating for 24 hours, (a–c) non-fixed EGFP-LEDGF-HaCaT cells and
(d–f) EGFP-HaCaT cells were immunolabeled with Blue, a nuclear-specific dye. Confocal images show (a, d) EGFP as green, (b, e) the nucleus as blue, and
(c, f) merged EGFP (green fluorescence) and nuclear (blue fluorescence) staining. Scale bars¼ 50mm. After 72 hours of incubation, the LEDGF mRNA and
protein levels in EGFP-LEDGF-HaCaT cells and EGFP-HaCaT cells were evaluated by (g) RT-PCR and (h) western blot, respectively. GAPDH was used to
normalize the gene expression. b-Actin was used as an internal loading control for the cell lysate samples in the western blot analysis. Statistical significance
between groups was assessed using paired Student’s t-test (n¼ 6). Error bars represent the SEM. *Po0.01. EGFP, enhanced green fluorescent protein;
GAPDH, glyceraldehyde 3 phosphate dehydrogenase; LEDGF, lens epithelium-derived growth factor; RT-PCR, reverse transcription-PCR.
2762 Journal of Investigative Dermatology (2010), Volume 130
T Takeichi et al.
LEDGF/DFS70 Induces IL-6 via p38 Phosphorylation
Therefore, we examined the effects of several MAPK
inhibitors to determine how specific signaling molecules
and pathways affect IL-6 expression in EGFP-LEDGF-HaCaT
cells. The cells were incubated for 24 hours in the presence or
absence of SP-600125 (10 mM), U-0126 (10 mM), SB-239063
(2 mM), or SB-203580 (2 mM). As shown in Figure 4a and b,
SP-600125, a specific c-Jun N-terminal kinase inhibitor
(Bennett et al., 2001), did not significantly affect IL-6 mRNA
production, but increased IL-6 protein expression. U-0126,
an extracellular signal-regulated kinase 1 and 2 inhibitor
(Duncia et al., 1998), stimulated the production of both IL-6
mRNA and protein. However, SB-239063 and SB-203580,
the specific inhibitors of p38 (Kramer et al., 1996; Under-
wood et al., 2000), blocked both IL-6 expression and
secretion (Figure 4a and b) (SB-203580, data not shown).
To determine whether p-p38 increased in EGFP-LEDGF-
HaCaT cells, we performed western blot analyses. Figure 4c
shows that the p-p38 (Thr 180/Tyr 182) levels were greater
in EGFP-LEDGF-HaCaT cells than in EGFP-HaCaT cells. In
addition, this increased p-p38 expression was downregulated
with SB-239063 (Figure 4d) and SB-203580 treatment (data
not shown), as expected.
Decreased IL-6 levels in EGFP-LEDGF-HaCaT cells transfected
with p38-specific siRNAs
To ascertain whether p38 phosphorylation is involved in IL-6
expression in cells overexpressing LEDGF/DFS70, siRNA was
used to knock down p38 mRNA (sip38) in EGFP-LEDGF-
HaCaT cells, as shown in Figure 5a, and the IL-6 mRNA and
protein levels were then measured. Figure 5c and d shows
that the IL-6 mRNA and protein levels were reduced to
approximately 60% compared with the controls when p38
protein and p-p38 protein levels were reduced by siRNA
(Figure 5b).
Effects of LEDGF-specific siRNAs on HSC-1 cells
HSC-1 cells, a human skin squamous cell carcinoma line,
were transfected with LEDGF siRNA (siLED) or a CD4 control
siRNA (siCD4). As shown in Supplementary Figure S3c and d
online, the IL-6 mRNA and protein levels were reduced upon
siLED-mediated reduction of LEDGF mRNA when compared
with the controls (Supplementary Figure S3a). Moreover,
p-p38 levels as well as IL-6 expression were reduced by
LEDGF siRNA (Supplementary Figure S3b).
LEDGF/DFS70 altered the expression of S100A7, S100A9, and
filaggrin
Because we expected that EGFP-LEDGF-HaCaT cells may
be a useful KC model for experimental psoriasis research, we
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Figure 3. Production of IL-6 mRNA and protein in EGFP-LEDGF-HaCaT
cells. IL-6 mRNA and protein expression in EGFP-LEDGF-HaCaT cells and
HaCaT cells was evaluated by (a) q-PCR and (b) ELISA, respectively. GAPDH
was used to normalize the gene expression. (c) Western blotting for pY-STAT3
in EGFP-LEDGF-HaCaT and EGFP-HaCaT cell extracts. The statistical
significance between groups was assessed using paired Student’s t-test (n¼ 4).
Error bars represent the SEM. *Po0.01. EGFP, enhanced green fluorescent
protein; GAPDH, glyceraldehyde 3 phosphate dehydrogenase; LEDGF, lens
epithelium-derived growth factor; q-PCR, quantitative PCR; STAT3, signal
transducer and activator of transcription 3.
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Figure 4. Effects of MAPK inhibitors on IL-6 expression and secretion in
EGFP-LEDGF-HaCaT cells. EGFP-LEDGF-HaCaT cells were incubated for
24 hours in the presence or absence of SP-600125 (10 mM), U0126 (10 mM),
or SB-239063 (2 mM). (a) The IL-6 mRNA levels were evaluated by q-PCR.
GAPDH was used to normalize the gene expression. (b) The amount of IL-6
secreted into the culture supernatant was determined by ELISA. (c) Lysates
from EGFP-LEDGF-HaCaT cells and EGFP-HaCaT cells that were cultured for
72 hours were examined by western blot analysis to detect the p-p38 levels.
(d) Western blotting of p-p38 extracted from EGFP-LEDGF-HaCaT cells that
were incubated for 24 hours in the presence or absence of SB-239063 (2 mM).
Statistical significance between groups was assessed using paired Student’s
t-test (n¼4). Error bars represent the SEM. *Po0.01; **Po0.05. EGFP,
enhanced green fluorescent protein; GAPDH, glyceraldehyde 3 phosphate
dehydrogenase; LEDGF, lens epithelium-derived growth factor; MAPK,
mitogen-activated protein kinase; p-p38, phosphorylated p38; q-PCR,
quantitative PCR.
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performed additional experiments to characterize this model.
S100A7 and S100A9 have been reported to be overexpressed
in psoriasis, whereas filaggrin has been shown to be
downregulated. To detect the levels of these molecules
in our system, we performed western blotting as shown in
Figure 6. The expression of the S100A7 and S100A9 proteins
in EGFP-LEDGF-HaCaT cells was higher than that in EGFP-
HaCaT cells. On the other hand, reduced filaggrin protein
expression was observed in EGFP-LEDGF-HaCaT cells when
compared with EGFP-HaCaT cells (Figure 6).
DISCUSSION
We previously reported that LEDGF/DFS70 is predominantly
localized in the nucleus of basal epidermal cells and
translocates into the cytoplasm during differentiation (Sugiura
et al., 2007). In this study we report that LEDGF/DFS70 as
well as p-STAT3 and p-p38 localize to the nucleus in both the
spinous and basal layers of psoriatic skin (Figure 1).
LEDGF/DFS70 is a nuclear protein that shows a character-
istic heterogeneous distribution in interphase cells and is
intimately associated with condensed chromosomes during
mitosis (Ochs et al., 2000; Maertens et al., 2003). LEDGF/
DFS70 interacts with Cdc7–ASK, a key kinase in S phase, and
stimulates its enzymatic activity in the nucleus (Hughes et al.,
2010). In view of these reports, LEDGF/DFS70 may also
function as a chromatin-associated protein in the nuclei of
proliferating KCs, such as in KCs in psoriatic lesions.
It has not been determined what induces LEDGF/DFS70 to
localize to the nucleus in KCs of psoriatic lesions. However,
we show that LEDGF/DFS70 localizes to the cytoplasm in
quiescent HaCaT cells after 3 days of starvation but localizes
to the nucleus in proliferating cells (Supplementary Figure S1
online). Therefore, it is very likely that LEDGF/DFS70
localizes to the nucleus of KCs in psoriatic lesions because
these KCs are actively proliferating and differentiating from
the suprabasal layer in the normal epidermis.
Previous studies have shown that LEDGF/DFS70 acts as a
survival factor (Singh et al., 1999). However, it was not
known whether LEDGF/DFS70 overexpression induces
growth factors or cytokines that direct cell growth until a
recent report demonstrated that vascular endothelial growth
factor C was induced by LEDGF/DFS70 in lung cancer cells
(Cohen et al., 2009). We showed that IL-6 was significantly
upregulated via the p38 MAPK pathway and that STAT3 was
activated in HaCaT cells constitutively expressing LEDGF/
DFS70 (Figures 3 and 4). Our findings that IL-6 was induced
through LEDGF/DFS70 in EGFP-LEDGF HaCaT cells was
further supported by the fact that IL-6 was reduced upon RNA
interference-mediated knockdown of LEDGF in these cells. In
addition, phosphorylated STAT3 in EGFP-LEDGF-HaCaT
cells was decreased upon siRNA-mediated knockdown of
IL-6 (data not shown). Our findings strongly suggested that
the overexpression of LEDGF/DFS70 in the nucleus of
psoriatic KCs could activate the IL-6/STAT3 pathway.
MAPKs are known to be key regulators of the expression of
many cytokines (Arthur and Darragh, 2006; Gazel et al., 2008).
We found that inhibitors and siRNAs specific to p38 MAPKs
significantly attenuated the IL-6 mRNA and protein levels in
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Figure 5. Decreased IL-6 levels in EGFP-LEDGF-HaCaT cells transfected
with p38-specific siRNAs. EGFP-LEDGF-HaCaT cells were transfected with
siRNAs specific for p38 (sip38) or CD4 (siCD4). After incubating the cells for
72 hours, the (a) p38 mRNA levels, and (b) the p38 and p-p38 protein levels
were evaluated by q-PCR and western blot analysis, respectively. (c) IL-6
mRNA and (d) IL-6 protein levels were also evaluated by q-PCR and ELISA,
respectively. GAPDH was used to normalize the gene expression. b-Actin was
used as an internal loading control for the cell lysates in the western blot
analysis. Statistical significance between groups was assessed using paired
Student’s t-test (n¼ 4). Error bars represent the SEM. *Po0.01. EGFP,
enhanced green fluorescent protein; GAPDH, glyceraldehyde 3 phosphate
dehydrogenase; LEDGF, lens epithelium-derived growth factor; p-p38,
phosphorylated p38; q-PCR, quantitative PCR; siRNA, small interfering RNA.
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Figure 6. Western blotting of EGFP-LEDGF-HaCaT cell lysates to examine
S100A7, S100A9, and filaggrin expression. EGFP-LEDGF-HaCaT (EGFP-
LEDGF) cells and EGFP-HaCaT (EGFP-vector) cells were incubated for 72hours
and then analyzed by western blotting for S100A7, S100A9, filaggrin, and b-actin.
b-Actin was used as an internal loading control. EGFP, enhanced green
fluorescent protein; LEDGF, lens epithelium-derived growth factor.
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EGFP-LEDGF-HaCaT cells (Figure 5). Previous reports
showed that p38 MAPKs regulate IL-6 (Zarubin and Han,
2005; Cuenda and Rousseau, 2007), which is consistent with
our data. However, it remains to be determined how LEDGF/
DFS70 induces p38 phosphorylation. Recent work has
shown that LEDGF can stimulate the enzymatic activity of
Cdc7–ASK, increasing the phosphorylation of MCM2 in vitro
(Hughes et al., 2010). In our model system, LEDGF/DFS70
may also interact with Cdc7–ASK, increasing MCM2 phos-
phorylation, and their interaction may be relevant to
activated p38 MAPK in these cells. We hope to determine
this mechanism in future studies.
We showed that LEDGF/DFS70 overexpression increased
the expression of psoriasis-associated molecules, including
S100A7 and S100A9, and reduced the expression of filaggrin
(Figure 6). S100A7 is a small calcium-binding protein, and
S100A7 mRNA is expressed in psoriatic skin lesions (Madsen
et al., 1991). S100A9 forms a noncovalent heterodimer with
S100A8, the calgranulin, and is highly expressed in psoriatic
skin (Broome et al., 2003). On the other hand, the filaggrin
protein is downregulated in psoriasis (Iizuka et al., 2004).
The expression of these proteins in psoriatic lesions is similar
to that observed in EGFP-LEDGF-HaCaT cells in this study.
Therefore, EGFP-LEDGF-HaCaT cells may be a useful
psoriatic KC in vitro model.
In summary, we showed that LEDGF/DFS70 localized to
the nucleus of KCs not only in the spinous layer but also in
the basal layer of psoriatic skin. We also demonstrated that
LEDGF/DFS70 regulated the IL-6/STAT3 signaling pathway
via p38 phosphorylation, S100A7, S100A9, and filaggrin in
LEDGF-transgenic HaCaT cells. These findings suggest that
LEDGF/DFS70 may have a pivotal role in activating psoriatic
KCs in vivo.
MATERIALS AND METHODS
Human skin tissues
Normal human skin was obtained from the scalp of a 16-year-old
patient with a benign scalp tumor and from the left anterior arm of a
37-year-old healthy individual. Psoriatic skin was obtained from
psoriatic lesions in 10 psoriasis patients (mean age 56 years; range
35–78). All skin tissue samples were taken after written informed
consent had been obtained. This study was approved by the ethics
committee of Nagoya University, Graduate School of Medicine, and
was conducted according to the Declaration of Helsinki Principles.
Antibodies and reagents
An antiserum against LEDGF/DFS70, named No. 6369 antiserum,
was acquired from the serum bank in our laboratory (Sugiura et al.,
2009). The following polyclonal antibodies were purchased
from commercial sources: anti-p-p38 (Thr 180/Tyr 182; Santa Cruz
Biotechnology, Santa Cruz, CA), anti-STAT3 (Ab-705; Signalway
Antibody, Pearland, TX), anti-STAT3 (phospho-Tyr705; Signalway
Antibody), anti-S100A7 (Abnova Corporation, Taipei, Taiwan),
anti-p38 (Abnova Corporation), and anti-b-actin (Sigma Aldrich,
St Louis, MO). The following monoclonal antibodies were purchased
from commercial sources: anti-S100A9 (Abnova Corporation),
anti-filaggrin (Abcam, Cambridge, UK), and anti-Ki-67 (Dako Santa
Barbara, CA). SP-600125, U-0126, and SB-239063 were purchased
from Sigma Aldrich. SB-203580 was also purchased from Enzo Life
Science (Farmingdale, NY). The sequences of the Taqman probes for
real-time quantitative PCR are shown in Supplementary Table S1a
online. The TaqMan Probes were purchased from TaqMan Gene
Expression Assays provided by Applied Biosystems (Foster City, CA).
siRNA sequences for LEDGF, p38, and CD4 are summarized in
Supplementary Table S1b online.
Cell culture and stable cell lines
The KC cell line HaCaT was kindly provided by N Fusenig (German
Cancer Research Center, Heidelberg, Germany) (Boukamp et al.,
1988). The skin squamous cell carcinoma cell line, HSC-1, was
obtained from the Japanese Collection of Research Bioresources
(Osaka, Japan). LEDGF complementary DNA was isolated by reverse
transcription–PCR from HeLa complementary DNA libraries and
inserted into the PstI sites of pEGFP-C1 (Clontech, Mountain View,
CA), creating EGFP-LEDGF. The plasmid was verified by sequence
analysis to confirm the absence of mutations. HaCaT and HSC-1
cells were cultured in DMEM containing 1.8mM calcium supple-
mented with 10% fetal calf serum at 37 1C with 5% CO2. For stable
transfections, HaCaT cells were cultured in 96-well dishes and then
transfected with 2 mg of the EGFP-LEDGF or EGFP-empty vector
plasmids that are geneticin (G418) resistant using Lipofectamine
transfection reagent (Invitrogen, Carlsbad, CA). After 2 days, the cells
were subcultured in the presence of 1mgml–1 of G418 (Roche Applied
Science, Mannheim, Germany). After approximately 2 weeks, single
G418-resistant colonies were obtained by serial dilution in 96-well
dishes. The colonies were maintained and analyzed individually for
expression of EGFP-LEDGF or the EGFP-empty vector.
Real-time quantitative PCR
HaCaT cells overexpressing LEDGF and empty vector-transfected
cells were seeded at 10,000 cells cm–2 and cultured for 72 hours in
DMEM containing 1.8mM calcium and 350mgml–1 G418 supple-
mented with 10% fetal bovine serum at 37 1C with 5% CO2. For the
study involving the MAPK inhibitors, EGFP-LEDGF-transfected
HaCaT cells were cultured in the presence or absence of the
following inhibitors when they reached 60% confluency: SP-600125
(10 mM), U-0126 (10 mM), SB-239063 (2mM), or SB-203580 (2 mM) with
350mgml–1 of G418. Total RNA was extracted from the cells at
different time points using an RNeasy Mini kit (Qiagen, Valencia,
CA) according to the manufacturer’s instructions. Complementary
DNA was synthesized from 250ng of total RNA using a random primer
procedure and the Takara RNA PCR kit, version 3.0 (Takara, Otsu,
Japan), according to the manufacturer’s instructions. Real-time quanti-
tative PCR was performed using a Sequence Detector System (Mx3000P
Real-Time PCR System and software; Stratagene, La Jolla, CA).
Amplification was performed in a final volume of 25ml that contained
10ng of complementary DNA from the reverse transcription reaction,
the primers and TaqMan probes, and 12.5ml TaqMan Universal PCR
Master Mix (Roche, Branchburg, NJ). The gene expression values were
normalized to glyceraldehyde 3 phosphate dehydrogenase to correct for
minor variations in mRNA extraction and reverse transcription. Each
experiment was performed at least three times.
Western blotting
Western blotting was performed as previously described (Sugiura
and Muro, 1999). In brief, strips of membrane were incubated with
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anti-LEDGF, anti-STAT3, anti-pY-STAT3, anti-p38, anti p-p38, anti-
S100A7, anti-S100A9, anti-profilaggrin, or anti-b-actin antibodies.
The antibody–antigen complexes were detected with horseradish
peroxidase–conjugated goat anti-mouse or anti-rabbit IgG (Dako,
Glostrup, Denmark) in a dilution of 1:1,000, followed by enhanced
chemiluminescence western blotting substrate (GE Healthcare Bio-
Sciences, Little Chalfont, UK), as described by the manufacturer.
ELISA for IL-6
To determine the level of secretory IL-6, cells were cultured in six-
well plates (density at 3.0 105 cells per cm2) for 72 and 96 hours
after being transfected with the indicated siRNAs. The medium was
collected and stored at 80 1C. The IL-6 content in the cultured
medium was determined by ELISA using a kit purchased from R&D
Systems (Minneapolis, MN).
RNA interference experiments
For the RNA interference experiments, HaCaT cells overexpressing
LEDGF were transfected with 5 nM siRNA specific for CD4, LEDGF,
or p38 using HiPerFect transfection reagent (Qiagen) according to
the manufacturer’s protocol.
Immunohistochemistry
Immunohistochemistry on human skin was performed as described
with slight modifications (Sugiura et al., 2007). The Vectastain Elite
ABC-PO (rabbit IgG) kit (Vector Laboratories, Burlingame, CA) was
used for staining. Thin sections (6mm) were cut from samples
embedded in paraffin blocks. The sections were immersed in a 0.4%
pepsin solution for 30minutes and soaked for 20minutes at room
temperature in 0.3% H2O2/methanol to block endogenous perox-
idase activity. After being washed in PBS with 0.01% Triton X-100,
the sections were incubated for 30minutes in PBS with 4% BSA
followed by an overnight incubation at 4 1C with the primary
antibodies (10 ngml–1) in PBS containing 1% BSA. After a washing in
PBS, the thin sections were stained with avidin-conjugated goat anti-
rabbit immunoglobulin secondary antibodies for 1 hour at room
temperature and washed in PBS. After a washing, the tissue sections
were immersed in Vectastain Elite ABC Reagent for 30minutes and
then washed in PBS. The antibody complexes were visualized by
adding 1% H2O2. Rabbit pre-immune serum (pre-immune no. 6369)
(Sugiura et al., 2007) corresponding to 10 ngml–1 was used as a
negative control.
Statistical analysis
An unpaired t-test was used to analyze the real-time PCR and ELISA
results. Po0.01 and Po0.05 were considered statistically significant.
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